What is the clinical evidence from this study?

Study design: Observational. Population: Cardiac myxomas (n=23). Intervention: Open cardiac surgery for tumor resection. Primary outcome: Early and late mortality.

What question did this study set out to answer?

To evaluate the clinical presentation, operative management, and early and late outcomes of patients undergoing open surgical resection of cardiac myxomas.

September 13, 2018The Heart Surgery ForumOpen Access

Surgical Treatment of Cardiac Myxomas: A 23-Case Experience

View Full Paper

Ask AI

Bookmark

Key result

Open cardiac surgery for resection of cardiac myxomas in 23 patients resulted in no early or late mortality.

Population

23 patients with cardiac myxomas electively operated on between January 2010 and August 2017, mean age 42.1…

Design

Case_series

Authors

AGAli Gür MAMehmet Coşkun Aykaç

Discussion

Member takes

Overview

May support safety of myxoma resection in selected cases; leaves open need for larger prospective validation.

Key Points

To evaluate the clinical presentation, operative management, and early and late outcomes of patients undergoing open surgical resection of cardiac myxomas.
Retrospective review of 23 patients (N=23; mean age 42.1 ± 8.9 years; 18 females, 5 males) who underwent elective open cardiac surgery between January 2010 and August 2017.
Preoperative tumor detection was performed using echocardiography in all patients, and all surgeries utilized cardiopulmonary bypass with aortic cross-clamping and bicaval cannulation.
Tumor localization occurred in the left atrium in 82.6% (n=19) and the right atrium in 17.4% (n=4) of cases, with tumor dimensions ranging from 2.5 × 1.5 cm to 8.5 × 6.5 cm.
All myxomas were resected with root solid tissue, followed by defect reconstruction via primary closure in 51.2% (n=12) or pericardial patch repair in 47.8% (n=11).
Both early and late postoperative mortality rates were 0% across all 23 resections.

Study Design

Type

Observational (n=23)

Multicenter

Structured PICO

Population

23 patients (72.3% female, mean age 42.1 years) electively operated on for cardiac tumors between 2010 and 2017.

Exposure

Surgical resection via open cardiac surgery (cardiopulmonary bypass with aortic cross-clamp and bicaval cannulation)

Outcome

Early and late mortalityhard clinical

Surgical resection of cardiac myxomas can be performed safely with excellent outcomes and no early or late mortality.

Cite This Study

Gür et al. (2018) conducted an observational in Cardiac myxomas (n=23). Open cardiac surgery for tumor resection was evaluated on Early and late mortality. Open cardiac surgery for resection of cardiac myxomas in 23 patients resulted in no early or late mortality.

synapsesocial.com/papers/6a9cbef4ccf76bb89d97a3d5 https://doi.org/10.1532/hsf.1987

View Full Paper

Ask AI

Bookmark

September 13, 2018The Heart Surgery ForumOpen Access

Surgical Treatment of Cardiac Myxomas: A 23-Case Experience

View Full Paper

Ask AI

Bookmark

Key result

Open cardiac surgery for resection of cardiac myxomas in 23 patients resulted in no early or late mortality.

Population

23 patients with cardiac myxomas electively operated on between January 2010 and August 2017, mean age 42.1…

Design

Case_series

Authors

AGAli Gür MAMehmet Coşkun Aykaç

Discussion

Member takes

Overview

May support safety of myxoma resection in selected cases; leaves open need for larger prospective validation.

Key Points

To evaluate the clinical presentation, operative management, and early and late outcomes of patients undergoing open surgical resection of cardiac myxomas.
Retrospective review of 23 patients (N=23; mean age 42.1 ± 8.9 years; 18 females, 5 males) who underwent elective open cardiac surgery between January 2010 and August 2017.
Preoperative tumor detection was performed using echocardiography in all patients, and all surgeries utilized cardiopulmonary bypass with aortic cross-clamping and bicaval cannulation.
Tumor localization occurred in the left atrium in 82.6% (n=19) and the right atrium in 17.4% (n=4) of cases, with tumor dimensions ranging from 2.5 × 1.5 cm to 8.5 × 6.5 cm.
All myxomas were resected with root solid tissue, followed by defect reconstruction via primary closure in 51.2% (n=12) or pericardial patch repair in 47.8% (n=11).
Both early and late postoperative mortality rates were 0% across all 23 resections.

Study Design

Type

Observational (n=23)

Multicenter

Structured PICO

Population

23 patients (72.3% female, mean age 42.1 years) electively operated on for cardiac tumors between 2010 and 2017.

Exposure

Surgical resection via open cardiac surgery (cardiopulmonary bypass with aortic cross-clamp and bicaval cannulation)

Outcome

Early and late mortalityhard clinical

Surgical resection of cardiac myxomas can be performed safely with excellent outcomes and no early or late mortality.

Cite This Study

synapsesocial.com/papers/6a9cbef4ccf76bb89d97a3d5 https://doi.org/10.1532/hsf.1987

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark